Vivani Medical (NASDAQ:VANI – Get Free Report) posted its earnings results on Monday. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01), Zacks reports.
Vivani Medical Stock Performance
NASDAQ VANI opened at $1.05 on Tuesday. The business’s fifty day moving average is $1.13 and its 200 day moving average is $1.21. The company has a market capitalization of $62.20 million, a PE ratio of -2.33 and a beta of 3.20. Vivani Medical has a fifty-two week low of $1.03 and a fifty-two week high of $2.22.
Analysts Set New Price Targets
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $4.00 target price on shares of Vivani Medical in a research note on Wednesday, March 26th.
About Vivani Medical
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Further Reading
- Five stocks we like better than Vivani Medical
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 5 Hot Stock Buys for Investors in April
- 5 discounted opportunities for dividend growth investors
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Earnings Per Share Calculator: How to Calculate EPS
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
